HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Mataix-Cols Selected Research

Tic Disorders (Tic Disorder)

10/2021Therapist-supported online remote behavioural intervention for tics in children and adolescents in England (ORBIT): a multicentre, parallel group, single-blind, randomised controlled trial.
9/2021Efficacy and cost-effectiveness of therapist-guided internet-delivered behaviour therapy for children and adolescents with Tourette syndrome: study protocol for a single-blind randomised controlled trial.
1/2021Association of Tourette Syndrome and Chronic Tic Disorder With Subsequent Risk of Alcohol- or Drug-Related Disorders, Criminal Convictions, and Death: A Population-Based Family Study.
1/2021Effectiveness of Behaviour Therapy for Children and Adolescents with Tourette Syndrome and Chronic Tic Disorder in a Naturalistic Setting.
1/2020Maternal polycystic ovary syndrome and risk of neuropsychiatric disorders in offspring: prenatal androgen exposure or genetic confounding?
1/2019Therapist-guided and parent-guided internet-delivered behaviour therapy for paediatric Tourette's disorder: a pilot randomised controlled trial with long-term follow-up.
11/2018Pharmacoepidemiology of Tourette and Chronic Tic Disorders in Sweden 2005-2013.
8/2015Familial Risks of Tourette Syndrome and Chronic Tic Disorders. A Population-Based Cohort Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David Mataix-Cols Research Topics

Disease

21Body Dysmorphic Disorders (Body Dysmorphic Disorder)
06/2022 - 06/2012
14Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
02/2021 - 03/2006
11Mental Disorders (Mental Disorder)
11/2022 - 01/2016
8Tourette Syndrome (Tourette's Syndrome)
06/2022 - 08/2015
8Tic Disorders (Tic Disorder)
10/2021 - 08/2015
5Tics (Tic)
10/2021 - 06/2010
4Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2021 - 11/2018
3Substance-Related Disorders (Drug Abuse)
01/2021 - 10/2019
3Social Phobia
01/2021 - 06/2012
3Sleep Initiation and Maintenance Disorders (Insomnia)
09/2020 - 01/2019
2Anxiety Disorders (Anxiety Disorder)
12/2019 - 11/2018
2Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2018 - 01/2017
2Bipolar Disorder (Manic Depressive Psychosis)
09/2015 - 09/2013
1Genetic Risk Score
12/2021
1Alcohol-Related Disorders
01/2021
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2020
1Autism Spectrum Disorder
01/2020
1Appendicitis
12/2019
1Inflammation (Inflammations)
12/2019
1Leukopenia
10/2019
1Epilepsy (Aura)
01/2018
1Autoimmune Diseases (Autoimmune Disease)
01/2018
1Birth Weight (Birth Weights)
11/2016
1Premature Birth (Birth, Premature)
11/2016
1Breech Presentation
11/2016
1Hoarding Disorder
02/2014
1Trichotillomania
02/2014
1Excoriation Disorder
02/2014
1Somatoform Disorders (Somatoform Disorder)
06/2012
1Streptococcal Infections (Streptococcal Infection)
05/2012
1Phobic Disorders (Phobia)
01/2005
1Panic Disorder (Panic Attack)
01/2005

Drug/Important Bio-Agent (IBA)

217,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA
06/2022 - 06/2012
5Pharmaceutical PreparationsIBA
01/2021 - 03/2006
5Cycloserine (Seromycin)FDA Link
12/2019 - 01/2014
3Biological ProductsIBA
11/2020 - 10/2019
3Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
10/2019 - 09/2015
3Antidepressive Agents (Antidepressants)IBA
11/2018 - 07/2015
2Biomarkers (Surrogate Marker)IBA
11/2020 - 10/2020
2AntibodiesIBA
10/2019 - 05/2012
2Psychotropic Drugs (Psychoactive Drugs)IBA
11/2018 - 01/2018
1DNA (Deoxyribonucleic Acid)IBA
12/2021
1A-factor (Streptomyces)IBA
02/2021
1AndrogensIBA
01/2020
1Antinuclear AntibodiesIBA
10/2019
1ORALIT (ORS)IBA
01/2019
1Adrenergic Antagonists (Antiadrenergic Agents)IBA
11/2018
1Anticonvulsants (Antiepileptic Drugs)IBA
11/2018
1BenzodiazepinesIBA
11/2018
1Quetiapine Fumarate (Seroquel)FDA Link
11/2018
1Aripiprazole (Abilify)FDA Link
11/2018
1Hypnotics and Sedatives (Sedatives)IBA
11/2018
1Antipsychotic Agents (Antipsychotics)IBA
11/2018
1Anti-Anxiety Agents (Anxiolytics)IBA
11/2018
1Prednisolone (Predate)FDA LinkGeneric
12/2016
1beta-cyclodextrin tetradecasulfate (CTDS)IBA
08/2015
1N-Methylaspartate (NMDA)IBA
07/2015
1SDMIBA
09/2013
1L 644711 (B-3(+))IBA
06/2010

Therapy/Procedure

19Therapeutics
11/2022 - 01/2005
2Combined Modality Therapy
09/2020 - 01/2019
1Ambulatory Care (Outpatient Care)
01/2021
1Aftercare (After-Treatment)
01/2021
1Drug Therapy (Chemotherapy)
01/2021
1Traction
11/2020
1Tonsillectomy
12/2019
1Obstetric Delivery
11/2016
1Cesarean Section (Caesarean Section)
11/2016